We are live on ! Find out more
PCM

Pinz Capital Management Portfolio holdings

AUM $55.2M
1-Year Est. Return 15.31%
This Fund
S&P 500
This Quarter Est. Return
+39.35%
1 Year Est. Return
-15.31%
3 Year Est. Return
+198.79%
5 Year Est. Return
10 Year Est. Return
AUM
$220M
AUM Growth
-$54.1M
Cap. Flow
-$78.7M
Cap. Flow %
-35.78%
Top 10 Hldgs %
26.66%
Holding
220
New
109
Increased
6
Reduced
7
Closed
98

Top Buys

Rank Stock Value
1
ABNB icon
Airbnb
ABNB
+$8.98M
2
DASH icon
DoorDash
DASH
+$7.34M
3
RGEN icon
Repligen
RGEN
+$6.62M
4
IQ icon
iQIYI
IQ
+$6.1M
5
OPCH icon
Option Care Health
OPCH
+$5.24M

Sector Composition

Rank Sector Weight
1 Healthcare 41.37%
2 Consumer Discretionary 16.02%
3 Technology 12.44%
4 Financials 7.11%
5 Industrials 6.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
STRO icon
26
Sutro Biopharma
STRO
$421M
$2.99M 1.36%
+13,780
New +$2.28M
ELAN icon
27
Elanco Animal Health
ELAN
$11.1B
$2.91M 1.32%
+94,900
New +$2.9M
KURA icon
28
Kura Oncology
KURA
$850M
$2.91M 1.32%
+89,100
New +$3.13M
NIO icon
29
NIO
NIO
$11.9B
$2.83M 1.28%
58,000
-46,600
-45% -$1.8M
SNDX icon
30
Syndax Pharmaceuticals
SNDX
$1.82B
$2.81M 1.28%
+126,352
New +$2.62M
ICHR icon
31
Ichor Holdings
ICHR
$2.56B
$2.76M 1.25%
+91,600
New +$2.59M
FOUR icon
32
Shift4
FOUR
$3.26B
$2.62M 1.19%
34,700
-96,362
-74% -$5.76M
ARRY icon
33
Array Technologies
ARRY
$855M
$2.57M 1.17%
+59,600
New +$2.4M
SYNH
34
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
$2.5M 1.14%
36,700
-16,620
-31% -$1.04M
CERT icon
35
Certara
CERT
$1.25B
$2.46M 1.12%
+73,100
New +$2.68M
VLRS
36
Controladora Vuela Compania de Aviacion
VLRS
$939M
$2.45M 1.11%
+197,273
New +$1.93M
RCKT icon
37
Rocket Pharmaceuticals
RCKT
$394M
$2.44M 1.11%
+44,550
New +$1.62M
GTM
38
ZoomInfo Technologies
GTM
$1.22B
$2.43M 1.11%
50,450
+6,950
+16% +$299K
NTLA icon
39
Intellia Therapeutics
NTLA
$1.67B
$2.39M 1.09%
+44,000
New +$1.6M
YSG
40
Yatsen Holding
YSG
$319M
$2.38M 1.08%
+27,940
New +$2.34M
FMTX
41
DELISTED
Forma Therapeutics Holdings, Inc. Common Stock
FMTX
$2.37M 1.08%
+68,000
New +$2.96M
RETA
42
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$2.35M 1.07%
+19,000
New +$2.5M
TWST icon
43
Twist Bioscience
TWST
$7.25B
$2.27M 1.03%
+16,050
New +$1.78M
JBLU icon
44
JetBlue
JBLU
$2.29B
$2.25M 1.02%
+155,050
New +$2.13M
FISV
45
Fiserv Inc
FISV
$27.9B
$2.22M 1.01%
19,500
+16,500
+550% +$1.78M
ATRA icon
46
Atara Biotherapeutics
ATRA
$76.1M
$2.17M 0.99%
+4,420
New +$2.04M
STOK icon
47
Stoke Therapeutics
STOK
$2.11B
$2.12M 0.96%
+34,200
New +$1.57M
STAG icon
48
STAG Industrial
STAG
$7.19B
$2.11M 0.96%
+67,400
New +$2.11M
MRVI icon
49
Maravai LifeSciences
MRVI
$919M
$2.09M 0.95%
+74,547
New +$2.08M
ONC
50
BeOne Medicines Ltd
ONC
$39.4B
$1.96M 0.89%
+7,600
New +$2.09M

Similar funds

Pinz Capital Management's Q4 2020 Portfolio in Review

As of Q4 2020, Pinz Capital Management held 220 positions worth $220M, down 20% from $274M the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Pinz Capital Management withdrew a net $78.7M in Q4 2020, closing 98 positions and reducing 7 holdings. Its most notable exit was iShares Russell 2000 ETF, an estimated $9.96M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 41% of assets, up from 26% a quarter earlier, followed by Consumer Discretionary and Technology.

Against the trend, Pinz Capital Management opened a new position in Airbnb worth $8.93M.

  • Pinz Capital Management's largest Q4 2020 buy was Airbnb: 60,800 shares worth $8.93M.
  • Pinz Capital Management added most to ProShares UltraPro Short QQQ in Q4 2020, an estimated $4.18M increase.
  • Pinz Capital Management's biggest Q4 2020 reduction was XPeng, cutting an estimated $9.11M.
  • Pinz Capital Management fully exited iShares Russell 2000 ETF in Q4 2020, selling an estimated $9.96M.
  • Pinz Capital Management's ten largest holdings make up 27% of its $220M portfolio in Q4 2020.
  • Pinz Capital Management opened 109 new positions and closed 98 in Q4 2020.
  • Pinz Capital Management's portfolio value fell 20% quarter-over-quarter to $220M.

Based on Pinz Capital Management's 13F filing for Q4 2020, filed 16 Feb 2021.